Growth Metrics

Cardlytics (CDLX) Cost of Revenue (2017 - 2025)

Cardlytics' Cost of Revenue history spans 9 years, with the latest figure at $7.5 million for Q4 2025.

  • For Q4 2025, Cost of Revenue fell 33.67% year-over-year to $7.5 million; the TTM value through Dec 2025 reached $39.5 million, down 25.02%, while the annual FY2025 figure was $39.5 million, 25.02% down from the prior year.
  • Cost of Revenue reached $7.5 million in Q4 2025 per CDLX's latest filing, down from $7.9 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $22.0 million in Q2 2022 to a low of $7.5 million in Q4 2025.
  • Average Cost of Revenue over 5 years is $14.5 million, with a median of $14.1 million recorded in 2023.
  • Peak YoY movement for Cost of Revenue: skyrocketed 63.99% in 2021, then tumbled 40.25% in 2025.
  • A 5-year view of Cost of Revenue shows it stood at $19.0 million in 2021, then decreased by 11.44% to $16.8 million in 2022, then decreased by 16.13% to $14.1 million in 2023, then dropped by 19.62% to $11.3 million in 2024, then crashed by 33.67% to $7.5 million in 2025.
  • Per Business Quant, the three most recent readings for CDLX's Cost of Revenue are $7.5 million (Q4 2025), $7.9 million (Q3 2025), and $11.3 million (Q2 2025).